Major considerations for facilities where any pharmaceuticals are manufactured or processed (including blood that will be used for transfusion) include space, organization, and cleanliness.
CFR Title 21 Part 211 Subpart C discusses areas that should be separate or in some way defined to prevent contamination and mix-ups.
Developing a logical workflow will also help with error reduction.
